Synonym:
3-(p-Aminophenyl)-3-ethylpiperidine-2,6-dione,
3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione,
DL-Aminoglutethimide
Properties:
Related Categories |
Analytical Standards,
Analytical/Chromatography,
EP Standards,
EP Standards A - B,
Pharmacopeia & Metrological Institutes Standards
|
Description:
Caution
Please find SDS provided by EDQM here..
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 125 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference subtance catalogue.
Biochem/physiol Actions
DL-Aminoglutethimide is a derivative of the sedative glutethimide. Originally introduced as an anticonvulsant, it was found to cause adrenal insufficiency. Blocks adrenal steroidogenesis by inhibiting the enzymatic conversion of cholesterol to pregnenolone. It also blocks the peripheral conversion (aromatization) of androgenic precursors to estrogens. The D-isomer is 30 times more potent at inhibiting aromatase activity, whereas the L-isomer is more potent at inhibiting cholesterol side-chain cleavage (steroidogenesis).
Safety:
Symbol
GHS07
Hazard statements
H315-H319-H335
Precautionary statements
P305 + P351 + P338
RIDADR
NONH for all modes of transport